Previous Article | Next Article 
Infection and Immunity, April 2003, p. 1849-1855, Vol. 71, No. 4
0019-9567/03/$08.00+0 DOI: 10.1128/IAI.71.4.1849-1855.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Development and Evaluation of an Improved Mouse Model of Meningococcal Colonization
Kyungcheol Yi,1* David S. Stephens,1,2,3 and Igor Stojiljkovic1
Department of Microbiology and Immunology,1
Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia 30322,2
Laboratories of Microbial Pathogenesis, Veterans Affairs Medical Center, Atlanta, Georgia 303033
Received 30 October 2002/
Returned for modification 16 December 2002/
Accepted 14 January 2003

ABSTRACT
Studies of meningococcal pathogenesis have been severely restricted
due to the absence of an adequate animal model. Given the significance
of iron in meningococcal pathogenesis, we developed a model
of
Neisseria meningitidis colonization in outbred adult mice
that included daily administration of iron dextran. While receiving
iron, the animals were inoculated intranasally with the initial
doses of bacterial suspension. Meningococci were recovered from
the animals by nasopharyngeal washes. Approximately half of
the animals inoculated with 10
7 CFU remained colonized 13 days
after the initial bacterial inoculation. The model was further
evaluated with genetically defined isogenic serogroup B mutant
strains, and the colonization capabilities of the mutants were
compared to that of the wild-type parent. A mutant that produces
truncated lipooligosaccharide (KDO
2-lipid A) and a mutant defective
in capsule transport were dramatically impaired in colonization.
A mutant defective in pilus transport (
pilQ) showed moderately
impaired colonization. The immunological aspect of the model
was also evaluated by challenging mice after immunization with
homologous whole-cell meningococci. The immunized mice were
protected from colonization of the homologous strain. In this
model, long-term meningococcal colonization was maintained,
allowing us to study the effects of specific genetic mutation
on colonization. In addition, this model allows investigation
of the role of active immune response against meningococci.

INTRODUCTION
Neisseria meningitidis is now the leading cause of serious bacterial
meningitis in the United States and is the leading cause in
many countries worldwide, despite effective antibiotics and
partially protective vaccines (
3). Meningococci commonly colonize
the nasopharynx of healthy individuals and can be isolated from
5 to 10% of the population in nonepidemic settings (
34). Meningococcal
acquisition in the nasopharynx may, in certain individuals,
progress to an invasive disease resulting in fatal meningitis
and/or sepsis.
Humans are the only natural host of meningococci. The bacterial virulence and colonization strategies are highly adapted to humans and have been difficult to study in animal models (41). Availability of iron is a major determinant of successful meningococcal infection, because iron is sequestered by the host, and an extremely low concentration of iron is maintained in the serum and at the mucosal surface. The inability of meningococci to cause disease in mice and other animals has been associated with the need of meningococci to use human transferrin or human lactoferrin as a source of iron (32). Meningococcal host specificity is due in part to the specificity of the iron-acquisition receptors on the surface of the bacteria, because the transferrin and lactoferrin receptors are specific for the corresponding human substrates (32, 33). This specificity for iron acquisition has restricted the development of the adequate animal model for studying the pathogenesis of meningococci. In this regard, enhancement of meningococcal virulence by the addition of iron in adult mice has been documented. Prior treatment of adult mice with human holo-transferrin causes bacteremia after intraperitoneal (i.p.) injection of the bacteria (14). Similarly, a parenteral dosage of iron dextran greatly enhances infection in animals challenged with meningococci (14).
Meningococcal disease has been modeled with infant mice, since infant rodents, for reasons not fully understood, are more susceptible to meningococci (29-31). Intranasal challenge with meningococci in infant mice produces invasive infection, mimicking the course of the meningococcal disease in humans (29). In the infant mouse model, administration of the iron to the animals further enhances the infection by the meningococci (20, 29-31). However, a major disadvantage of the infant mouse/rat model is the narrow window of infection, because mice and rats over 10 days old do not show signs of meningococcal disease (20, 31).
Recently, an animal model of Neisseria gonorrhoeae, a close relative of meningococcus, was developed in female BALB/c mice as a surrogate model for human infection (15). Prolonged genital tract infection in mice was achieved by treatment with estradiol and antibiotics. In this study, we have developed a convenient and economical animal model using adult outbred mice. Utilizing the importance of iron in the pathogenesis of meningococcus, we were able to establish colonization in the nasopharynx of the mouse by administering an iron source systemically and locally. Because meningococcal nasopharyngeal colonization is the first step of host-parasite interaction in the natural meningococcal infection, we first addressed these events by using this model. The model provides insight into understanding the early events of meningococcal disease.

MATERIALS AND METHODS
Bacterial strains.
The meningococcal strains used in this study are listed in Table
1. A spontaneous streptomycin-resistant strain was selected
as a reference strain from a clinical isolate, with a serogroup
B
N. meningitidis strain, IR2781 (
27). Meningococci were grown
on GC medium base (Difco, Becton Dickinson, Sparks, Md.) plates
(GCB plates) containing Kellog's supplements and incubated at
37°C under 5% CO
2 tension or in liquid cultures in GC broth
containing Kellog's supplements at 37°C with 5% CO
2 with
agitation
. When necessary, appropriate antibiotics were added
to the medium as follows: streptomycin, 750 µg/ml; kanamycin,
100 µg/ml; and spectinomycin, 70 µg/ml. Transformation
was performed as previously described (
27).
Mouse model.
Female outbred mice [Swiss Webster, Crl:CFW(SW) BR, Charles
River Laboratories] were used for most of the experiments. In
some experiments, complement-deficient mice (CDM) (B10.D2-H2
d H2-T18
c Hc
0/oSnJ; Jackson Laboratories) were used. These CDM
lack the C5 component of the complement pathway. Mice received
200 mg of iron dextran (Dexferrum; American Regent Laboratories)
per kg of body weight i.p. in 100 µl 2 to 3 h before intranasal
inoculation with meningococci. Designated numbers of CFU of
meningococci in 20 µl of GC broth were atraumatically
inoculated into the right nare of the animal. After 3 h of the
meningococcal inoculation, 15 µl of iron dextran (50 µg/µl)
was given intranasally. The i.p. iron dextran was administered
once a day during the duration of the colonization experiment.
In some instances, human holo-transferrin (Sigma) in 200 µl
of phosphate-buffered saline (PBS) (pH 7.4) was injected into
the mice (800 mg per body weight) in the place of iron dextran.
Human holo-transferrin was used for the subsequent intranasal
inoculation (1.5 mg per mouse in a volume of 15 µl) and
for the daily dosage. Nasopharyngeal washes were carried out
by nasally instilling 35 µl of GC broth. Liquid was recovered
from the mouth and plated on the modified Thayer-Martin medium
to monitor for meningococcus growth. The number (percentage)
of mice colonized with meningococci over a period of 13 days
was monitored.
ELISA.
The enzyme-linked immunosorbent assay (ELISA) was performed as follows. Levels of immunoglobulin A (IgA) to the homologous strain were assayed in the nasopharyngeal washes of the mice colonized with the wild-type strain for 13 days or longer. The wells of microtiter plates (Maxisorp; Nunc) were coated overnight at 4°C with the whole-cell bacteria. Prior to coating, bacteria were grown overnight on GCB plates and resuspended in coating buffer (0.1 M sodium carbonate, 0.1 M sodium bicarbonate, pH 9.6) to an optical density at 600 nm (OD600) of 0.2. The wells were blocked with 3% bovine serum albumin (Sigma) in PBS for 1 h. Nasopharyngeal washes were collected as described above, and the volumes were adjusted to 100 µl. The washes were placed in the coated microtitier wells and probed with horseradish peroxidase-labeled antimouse IgA (Sigma). Reactions were visualized by applying the wells with tetramethylbenzidine with hydrogen peroxide (TMB Soluble; Calbiochem) and read at 630 nm after a 30-min incubation.
Immunization.
Mice were immunized with viable whole bacteria of N. meningitidis strain IR2781 suspended in PBS. Bacteria were first grown on GCB plates overnight as described above. The bacterial cells were resuspended in PBS (pH 7.4) to an OD600 of 0.4. The mice received 100 µl of resuspended bacterial preparation i.p. Additional i.p. immunizations were performed twice at 9-day intervals.
Statistical analysis.
All of the mouse colonization data were subjected to statistical analysis to determine significance. The Kaplan-Meier method was used to estimate cumulative clearance. Cumulative clearance between groups (strains, challenges, and inoculum sizes) was compared by log-rank tests. Statistical tests were two sided. A P value of
0.05 was considered statistically significant. The data from the ELISA reading were analyzed by using a one-sample test (see Fig. 2).

RESULTS
Model for meningococcal colonization of outbred mice.
Outbred adult mice (Swiss Webster) were selected in an effort
to closely reflect colonization of human populations. A daily
dose of systemic iron was required to establish meningococcal
colonization of outbred adult mice. In addition, intranasal
local priming with iron dextran on day 0 was necessary to have
all of the mice colonized on day 1. In contrast to the work
of Jerse with gonococcus (
15), prior antibiotic treatment of
mice was not necessary for meningococcal colonization in our
experiments (data not shown). The number (percentage) of mice
colonized with meningococci over 13 days was plotted (Fig.
1).
Three groups of mice intranasally received the serogroup B wild-type
strain (IR4127) at 10
7, 10
6, and 10
5 CFU, respectively. Forty-two
percent of the mice inoculated with 10
7 CFU remained colonized
with meningococci after 13 days (Fig.
1). The cumulative clearance
between the inoculum sizes was statistically different (
P =
0.001) by the log-rank test. Nasopharyngeal washes from mice
that had been colonized for more than 13 days contained mouse
IgA to the homologous meningococcus strain, indicating the presence
of active mucosal immune responses against colonizing meningococci
(Fig.
2).
Colonization of adult mice with mutants.
Adult mice were intranasally challenged with meningococcus mutants
to evaluate the roles of specific genes in meningococcal colonization.
First, three mutants that did not express wild-type lipooligosaccharide
(LOS) due to inactivation of the LOS biosynthesis genes (
rfaC,
lgtF, and
lst) were studied. These mutants produce truncated
LOS molecules: the
rfaC mutant synthesizes only KDO
2-lipid A
(
18), while the
lgtF mutant expresses the Hep
2(GlcNAc)KDO
2-lipid
A (
17,
18). The LOS from the
lst mutant is not sialylated due
to a defect in LOS sialyltransferase (
17,
18). Figure
3 represents
the number of mice colonized with corresponding mutant strains
in three groups. The
rfaC mutant (IR5389) was severely impaired
in the colonization capability, while the
lgtF (IR5475) and
lst (IR5476) mutants showed moderately attenuated colonization.
Likewise, the capsule-deficient
ctrA strain (IR5390) showed
severely impaired colonization (Fig.
3). The
ctrA mutant is
capsule deficient due to inability to transport the capsule
to the cell surface. As another control, a
pilQ mutant that
does not allow pilus biogenesis was examined (
8). The PilQ protein
functions in the terminal process of pilus expression, and inactivation
of the gene affects the competence for the natural transformation
(
8). The
pilQ mutant was moderately impaired in colonization
(Fig.
3). The cumulative clearance was statistically different
between the wild-type and mutant strains (
P < 0.001) by the
log-rank test.
The in vitro growth rates of the mutants were compared with
that of wild-type parent to determine whether gene inactivation
affected the growth of the mutants, which could reduce the degree
of the nasopharyngeal colonization. The mutants grew at rates
similar to that of the wild type, indicating that the gene inactivation
of the mutants did not affect the in vitro growth of the bacteria
(Fig.
3, insert).
Role of complement in the colonization of rfaC and ctrA mutant strains.
Complement-mediated bactericidal activity is the major defense mechanism against meningococcal infection (7, 19, 25). Capsule and LOS appeared to play critical roles in meningococcal colonization in normal adult mice, because mutants devoid of capsule or expressing a truncated LOS (rfaC) failed to effectively colonize in this model. This led us to further investigate the role of complement in the colonization of the rfaC and ctrA mutants by using CDM. Complement was partially responsible for the failure of colonization for both mutants, since colonization by the mutants was partially restored in the CDM (Fig. 4). The cumulative clearance between four test groups was compared by the log-rank test (P < 0.001).
Effect of immunization on colonization of the mouse nasopharynx by meningococci.
The effect of parenteral immunization on colonization of adult
mice by nasopharyngeal administration of the homologous meningococcus
strain was evaluated. The animals were intranasally challenged
after a course of three immunizations with the whole bacterial
cell (see Materials and Methods). None of the immunized mice
became colonized with the homologous strain, indicating that
the parenteral immunization effectively protects mice from nasopharyngeal
colonization by homologous meningococci (Fig.
5). ELISA detected
a high level of serum IgG to the homologous strain in sera from
all immunized mice, while IgA was not detected (data not shown).

DISCUSSION
The in vivo study of meningococcal pathogenesis has been severely
restricted by the pathogen's strict host specificity and the
morbidity and mortality of human disease. An animal model of
meningococcal colonization to study the initial course of the
disease and to facilitate the development of better vaccines
is critically needed. Studies with infant rodents had limited
success in producing bacteremia by intranasal inoculation (
20).
The animals were 4 to

5 days old at the beginning of the experiment
and maintained susceptibility for the next 5 days. This study
describes the establishment of a model of long-term nasopharyngeal
meningococcus colonization of adult mice by supplying the animals'
daily iron. Both daily systemic iron dextran and intranasal
priming with iron dextran were required to initiate colonization.
The importance of iron related to meningococcal virulence in
mice has been studied extensively (
13,
14). We tested both human
holo-transferrin and iron dextran to facilitate meningococcal
colonization. Both iron sources supported the bacterial colonization
in mice when given i.p. (human transferrin data not shown).
However, iron dextran was chosen for the challenges because
(i) iron dextran is relatively economical and showed very low
toxicity (
14), and (ii) the iron moiety was complexed with dextran,
a low-molecular-weight polyglucose (
4). Dextran is cleared rapidly
by either metabolism or excretion. Parenteral administration
of human transferrin may lead to immune responses, which should
influence the model.
A previous study by Mackinnon et al. (21) showed that the nasal colonization usually accompanied lung infection in the infant mice. In this study, animals colonized in their nasopharynxes did not have any viable bacteria in the lung.
Curiously, reducing the amount of normal flora in the nasopharyngeal cavity by antibiotic treatment did not affect the outcome of the colonization (data not shown). In the mouse model of gonococcal genital tract infection, antibiotic treatment was required to suppress inhibitory normal flora.
Binding of pilus to the host mucosal surface is an initial step in colonization (26, 35, 36, 39). Primary adherence by pili to the epithelial cells is followed by intimate contacts with secondary surface molecules, such as Opa/Opc proteins (6). The mouse colonization model with a pilQ mutant revealed that the mutant colonized less efficiently than the parent strain. Bacterial surface components other than pili contribute to bacterial adhesion to epithelial and endothelial cells (24, 28, 46). In the absence of proper pilus assembly function, Opc and Opa may facilitate adhesion of meningococci to the eukaryotic cells, especially if capsule expression is turned off or downregulated (44, 45)
Previous studies with capsule-defective mutants in an infant rat model demonstrated the importance of capsule for bacteremia (47). We found that capsule is required for effective colonization in our model and that complement is partially responsible for the defect in the ability of the capsule-deficient mutant to colonize.
The role of LOS in the pathogenesis of meningococci and gonococci has been studied extensively. Gonococcal LOS plays a role in the adherence of the organism to host cells in vitro (5, 23, 43). In an infant rat model, the meningococcus mutant defective in LOS sialylation did not cause bacteremia, even with a high dose of CFU (47). In our mouse model, an rfaC mutant with a truncated LOS structure (KDO2-lipid A) did not colonize. An earlier study with the same mutant showed its inability to cause bacteremia (37). Interestingly, an lgtF mutant, which had three additional inner core glycosyl residues on the LOS molecule compared with the rfaC mutant, and an lst mutant (sialylation defective) showed only moderately attenuated colonization (Fig. 3). The lgtF and lst mutants were similar in our assay despite the differences in the length of the truncated LOS, suggesting a role for LOS core structure in colonization.
The incidence of meningococcal disease inversely correlates to the level of bactericidal antibodies in human serum (9, 10). The role of complement-mediated bactericidal activity has been evidenced by the susceptibility to meningococcus of individuals deficient in the terminal component of complement. The role of antibodies to meningococci in preventing mucosal colonization has been documented. The rate of carriage of serogroup C was reduced in a group of military recruits vaccinated with the polysaccharide capsule from serogroup C or a combination of capsule polysaccharides from serogroups A and C (11, 38). These studies indirectly suggest a protective role of humoral antibodies in mucosal colonization. In other vaccine trials, however, vaccination with serogroup A capsule did not grant a reduction in carriage rate (2, 12). More recently, a significant mucosal immune response has been observed in young adults after immunization with meningococcal A+C conjugate and polysaccharide vaccines (1). Vaccination with meningococcal C conjugate polysaccharide reduced the rate of carriage of serogroup C meningococci by 66% among an adolescent population (22). In this study, hyperimmune mice with whole meningococci were protected from mucosal colonization by the homologous strain. Our results suggest that parenteral immunization could potentially prevent colonization and thereby prevent transmission.
In summary, a model for meningococcal colonization was developed with adult outbred mice. The colonization capabilities of several mutants and the prevention of colonization by immunization were demonstrated. While this model does not accurately mimic all aspects of interactions between the human nasopharyngeal tissue and meningococci, because the organism is highly adapted to humans and its receptors (CD46, human transferrin, lactoferrin, etc.), the model will allow us to study early events of meningococcal pathogenesis.

ACKNOWLEDGMENTS
We thank Anthony Richardson for helpful suggestions.
This study was supported by an Emory University Research Committee award and Public Health Service grant AI472870-01A1.

FOOTNOTES
* Corresponding author. Mailing address: Department of Microbiology and Immunology, Emory University School of Medicine, 1510 Clifton Rd. NE, Atlanta, GA 30322. Phone: (404) 727-5968. Fax: (404) 727-3659. E-mail:
kyi{at}emory.edu.

Editor: F. C. Fang

REFERENCES
1 - Balmer, P., R. Borrow, and E. Miller. 2002. Impact of meningococcal C conjugate vaccine in the UK. J. Med. Microbiol. 51:717-722.[Abstract/Free Full Text]
2 - Blakebrough, I. S., B. M. Greenwood, H. C. Whittle, A. K. Bradley, and H. M. Gilles. 1983. Failure of meningococcal vaccination to stop the transmission of meningococci in Nigerian schoolboys. Ann. Trop. Med. Parasitol. 77:175-178.[Medline]
3 - Centers for Disease Control and Prevention. 1997. Control and prevention of meningococcal disease and control and prevention of serogroup C meningococcal disease: evaluation and management of suspected outbreaks. Morb. Mortal. Wkly. Rep. 46:1-21.[Medline]
4 - Cox, J. S., G. R. Kennedy, J. King, P. R. Marshall, and D. Rutherford. 1972. Structure of an iron-dextran complex. J. Pharm. Pharmacol. 24:513-517.[Medline]
5 - Dehio, C., S. D. Gray-Owen, and T. F. Meyer. 2000. Host cell invasion by pathogenic neisseriae. Subcell. Biochem. 33:61-96.[Medline]
6 - Dehio, C., S. D. Gray-Owen, and T. F. Meyer. 1998. The role of neisserial Opa proteins in interactions with host cells. Trends Microbiol. 6:489-495.[CrossRef][Medline]
7 - Densen, P., J. M. Weiler, J. M. Griffiss, and L. G. Hoffmann. 1987. Familial properdin deficiency and fatal meningococcemia. Correction of the bactericidal defect by vaccination. N. Engl. J. Med. 316:922-926.[Medline]
8 - Drake, S. L., and M. Koomey. 1995. The product of the pilQ gene is essential for the biogenesis of type IV pili in Neisseria gonorrhoeae. Mol. Microbiol. 18:975-986.[CrossRef][Medline]
9 - Goldschneider, I., E. C. Gotschlich, and M. S. Artenstein. 1969. Human immunity to the meningococcus. I. The role of humoral antibodies. J. Exp. Med. 129:1307-1326.[Abstract]
10 - Goldschneider, I., E. C. Gotschlich, and M. S. Artenstein. 1969. Human immunity to the meningococcus. II. Development of natural immunity. J. Exp. Med. 129:1327-1348.[Abstract]
11 - Gotschlich, E. C., I. Goldschneider, and M. Artenstein. 1969. Human immunity to the meningococcus. V. The effect of immunization with meningococcal group C polysaccharide on the carrier state. J. Exp. Med. 129:1385-1395.[Abstract]
12 - Hassan-King, M. K., R. A. Wall, and B. M. Greenwood. 1988. Meningococcal carriage, meningococcal disease and vaccination. J. Infect. Dis. 16:55-59.
13 - Holbein, B. E. 1981. Enhancement of Neisseria meningitidis infection in mice by addition of iron bound to transferrin. Infect. Immun. 34:120-125.[Abstract/Free Full Text]
14 - Holbein, B. E. 1980. Iron-controlled infection with Neisseria meningitidis in mice. Infect. Immun. 29:886-891.[Abstract/Free Full Text]
15 - Jerse, A. E. 1999. Experimental gonococcal genital tract infection and opacity protein expression in estradiol-treated mice. Infect. Immun. 67:5699-5708.[Abstract/Free Full Text]
16 - Kahler, C. M., R. W. Carlson, M. M. Rahman, L. E. Martin, and D. S. Stephens. 1996. Two glycosyltransferase genes, lgtF and rfaK, constitute the lipooligosaccharide ice (inner core extension) biosynthesis operon of Neisseria meningitidis. J. Bacteriol. 178:6677-6684.[Abstract/Free Full Text]
17 - Kahler, C. M., L. E. Martin, G. C. Shih, M. M. Rahman, R. W. Carlson, and D. S. Stephens. 1998. The (
2
8)-linked polysialic acid capsule and lipooligosaccharide structure both contribute to the ability of serogroup B Neisseria meningitidis to resist the bactericidal activity of normal human serum. Infect. Immun. 66:5939-5947.[Abstract/Free Full Text]
18 - Kahler, C. M., and D. S. Stephens. 1998. Genetic basis for biosynthesis, structure, and function of meningococcal lipooligosaccharide (endotoxin). Crit. Rev. Microbiol. 24:281-334.[Medline]
19 - Lehner, P. J., K. A. Davies, M. J. Walport, A. P. Cope, R. Wurzner, A. Orren, B. P. Morgan, and J. Cohen. 1992. Meningococcal septicaemia in a C6-deficient patient and effects of plasma transfusion on lipopolysaccharide release. Lancet 340:1379-1381.[CrossRef][Medline]
20 - Mackinnon, F. G., R. Borrow, A. R. Gorringe, A. J. Fox, D. M. Jones, and A. Robinson. 1993. Demonstration of lipooligosaccharide immunotype and capsule as virulence factors for Neisseria meningitidis using an infant mouse intranasal infection model. Microb. Pathog. 15:359-366.[CrossRef][Medline]
21 - Mackinnon, F. G., A. R. Gorringe, S. G. Funnell, and A. Robinson. 1992. Intranasal infection of infant mice with Neisseria meningitidis. Microb. Pathog. 12:415-420.[CrossRef][Medline]
22 - Maiden, M. C., J. M. Stuart, and the UK Meningococcal Carriage Group. 2002. Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination. Lancet 359:1829-1831.[CrossRef][Medline]
23 - Merz, A. J., and M. So. 2000. Interactions of pathogenic neisseriae with epithelial cell membranes. Annu. Rev. Cell. Dev. Biol. 16:423-457.[CrossRef][Medline]
24 - Nassif, X., C. Pujol, P. Morand, and E. Eugene. 1999. Interactions of pathogenic Neisseria with host cells. Is it possible to assemble the puzzle? Mol. Microbiol. 32:1124-1132.[CrossRef][Medline]
25 - Ram, S., F. G. Mackinnon, S. Gulati, D. P. McQuillen, U. Vogel, M. Frosch, C. Elkins, H. K. Guttormsen, L. M. Wetzler, M. Oppermann, M. K. Pangburn, and P. A. Rice. 1999. The contrasting mechanisms of serum resistance of Neisseria gonorrhoeae and group B Neisseria meningitidis. Mol. Immunol. 36:915-928.[CrossRef][Medline]
26 - Rayner, C. F., A. Dewar, E. R. Moxon, M. Virji, and R. Wilson. 1995. The effect of variations in the expression of pili on the interaction of Neisseria meningitidis with human nasopharyngeal epithelium. J. Infect. Dis. 171:113-121.[Medline]
27 - Richardson, A. R., and I. Stojiljkovic. 1999. HmbR, a hemoglobin-binding outer membrane protein of Neisseria meningitidis, undergoes phase variation. J. Bacteriol. 181:2067-2074.[Abstract/Free Full Text]
28 - Rudel, T., J. P. van Putten, C. P. Gibbs, R. Haas, and T. F. Meyer. 1992. Interaction of two variable proteins (PilE and PilC) required for pilus-mediated adherence of Neisseria gonorrhoeae to human epithelial cells. Mol. Microbiol. 6:3439-3450.[Medline]
29 - Salit, I. E., and L. Tomalty. 1986. Experimental meningococcal infection in mice: a model for mucosal invasion. Infect. Immun. 51:648-652.[Abstract/Free Full Text]
30 - Salit, I. E., and L. Tomalty. 1986. A neonatal mouse model of meningococcal disease. Clin. Investig. Med. 9:119-123.[Medline]
31 - Salit, I. E., E. Van Melle, and L. Tomalty. 1984. Experimental meningococcal infection in neonatal animals: models for mucosal invasiveness. Can. J. Microbiol. 30:1022-1029.[Medline]
32 - Schryvers, A. B., and G. C. Gonzalez. 1989. Comparison of the abilities of different protein sources of iron to enhance Neisseria meningitidis infection in mice. Infect. Immun. 57:2425-2429.[Abstract/Free Full Text]
33 - Schryvers, A. B., and I. Stojiljkovic. 1999. Iron acquisition systems in the pathogenic Neisseria. Mol. Microbiol. 32:1117-1123.[CrossRef][Medline]
34 - Stephens, D. S. 1999. Uncloaking the meningococcus: dynamics of carriage and disease. Lancet 353:941-942.[CrossRef][Medline]
35 - Stephens, D. S., L. H. Hoffman, and Z. A. McGee. 1983. Interaction of Neisseria meningitidis with human nasopharyngeal mucosa: attachment and entry into columnar epithelial cells. J. Infect. Dis. 148:369-376.[Medline]
36 - Stephens, D. S., and Z. A. McGee. 1981. Attachment of Neisseria meningitidis to human mucosal surfaces: influence of pili and type of receptor cell. J. Infect. Dis 143:525-532.[Medline]
37 - Stojiljkovic, I., V. Hwa, J. Larson, L. Lin, M. So, and X. Nassif. 1997. Cloning and characterization of the Neisseria meningitidis rfaC gene encoding alpha-1,5 heptosyltransferase I. FEMS Microbiol. Lett. 151:41-49.[Medline]
38 - Stroffolini, T., L. Angelini, I. Galanti, M. Occhionero, M. E. Congiu, and P. Mastrantonio. 1990. The effect of meningococcal group A and C polysaccharide vaccine on nasopharyngeal carrier state. Microbiologica 13:225-229.[Medline]
39 - Swanson, J. 1973. Studies on gonococcus infection. IV. Pili: their role in attachment of gonococci to tissue culture cells. J. Exp. Med. 137:571-589.[Abstract]
40 - Swartley, J. S., J. H. Ahn, L. J. Liu, C. M. Kahler, and D. S. Stephens. 1996. Expression of sialic acid and polysialic acid in serogroup B Neisseria meningitidis: divergent transcription of biosynthesis and transport operons through a common promoter region. J. Bacteriol. 178:4052-4059.[Abstract/Free Full Text]
41 - Tauber, M. G., and A. Zwahlen. 1994. Animal models for meningitis. Methods Enzymol. 235:93-106.[CrossRef][Medline]
42 - Tonjum, T., D. A. Caugant, S. A. Dunham, and M. Koomey. 1998. Structure and function of repetitive sequence elements associated with a highly polymorphic domain of the Neisseria meningitidis PilQ protein. Mol. Microbiol. 29:111-124.[CrossRef][Medline]
43 - van Putten, J. P. 1993. Phase variation of lipopolysaccharide directs interconversion of invasive and immuno-resistant phenotypes of Neisseria gonorrhoeae. EMBO J. 12:4043-4051.[Medline]
44 - Virji, M., K. Makepeace, D. J. Ferguson, M. Achtman, and E. R. Moxon. 1993. Meningococcal Opa and Opc proteins: their role in colonization and invasion of human epithelial and endothelial cells. Mol. Microbiol. 10:499-510.[Medline]
45 - Virji, M., K. Makepeace, D. J. Ferguson, M. Achtman, J. Sarkari, and E. R. Moxon. 1992. Expression of the Opc protein correlates with invasion of epithelial and endothelial cells by Neisseria meningitidis. Mol. Microbiol. 6:2785-2795.[CrossRef][Medline]
46 - Virji, M., J. R. Saunders, G. Sims, K. Makepeace, D. Maskell, and D. J. Ferguson. 1993. Pilus-facilitated adherence of Neisseria meningitidis to human epithelial and endothelial cells: modulation of adherence phenotype occurs concurrently with changes in primary amino acid sequence and the glycosylation status of pilin. Mol. Microbiol. 10:1013-1028.[Medline]
47 - Vogel, U., S. Hammerschmidt, and M. Frosch. 1996. Sialic acids of both the capsule and the sialylated lipooligosaccharide of Neisseria meningitidis serogroup B are prerequisites for virulence of meningococci in the infant rat. Med. Microbiol. Immunol. 185:81-87.[CrossRef][Medline]
Infection and Immunity, April 2003, p. 1849-1855, Vol. 71, No. 4
0019-9567/03/$08.00+0 DOI: 10.1128/IAI.71.4.1849-1855.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Zarantonelli, M.-L., Szatanik, M., Giorgini, D., Hong, E., Huerre, M., Guillou, F., Alonso, J.-M., Taha, M.-K.
(2007). Transgenic Mice Expressing Human Transferrin as a Model for Meningococcal Infection. Infect. Immun.
75: 5609-5614
[Abstract]
[Full Text]
-
Zhu, D., Zhang, Y., Barniak, V., Bernfield, L., Howell, A., Zlotnick, G.
(2005). Evaluation of Recombinant Lipidated P2086 Protein as a Vaccine Candidate for Group B Neisseria meningitidis in a Murine Nasal Challenge Model. Infect. Immun.
73: 6838-6845
[Abstract]
[Full Text]
-
Gudlavalleti, S. K., Datta, A. K., Tzeng, Y.-L., Noble, C., Carlson, R. W., Stephens, D. S.
(2004). The Neisseria meningitidis Serogroup A Capsular Polysaccharide O-3 and O-4 Acetyltransferase. J. Biol. Chem.
279: 42765-42773
[Abstract]
[Full Text]
-
Yi, K., Rasmussen, A. W., Gudlavalleti, S. K., Stephens, D. S., Stojiljkovic, I.
(2004). Biofilm Formation by Neisseria meningitidis. Infect. Immun.
72: 6132-6138
[Abstract]
[Full Text]
-
van der Woude, M. W., Baumler, A. J.
(2004). Phase and Antigenic Variation in Bacteria. Clin. Microbiol. Rev.
17: 581-611
[Abstract]
[Full Text]